Manila Times Business
CancerVax Successfully Demonstrates Full Nanoparticle Delivery in Mouse Study
First biodistribution study of the Company’s complete cancer targeting nanoparticle avoided many healthy organs Lehi, UT, June 15, 2026 (GLOBE NEWSWIRE) -- CancerVax Successfully Demonstrates Full Nanoparticle Delivery in Mouse Study First biodistribution study of the Company’s complete cancer targeting nanoparticle avoided many healthy organs Lehi, Utah, June 15, 2026 - CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that "tricks” the body’s immune system in
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Cebu gets a bold new beat as Radisson RED makes its Philippine debut
1h ago
Manz Asia Successfully Delivers World's First 310mm × 310mm Panel-Level Packaging ECD Production System
1h ago
Form 8.3 - [ANIMALCARE GROUP PLC - 12 06 2026] - (CGWL)
1h ago
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 12 06 2026] - (CGWL)
1h ago